← The Wire
CMPXNasdaq
Compass Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1738021
Developing antibody-based cancer therapeutics targeting angiogenesis, immune response, and tumor growth
$366M
Market cap
$2.16
Last close
+3.9%
1D
+2.9%
5D
2.8M
Volume
Price · last 39 sessions+11.3%
May 4L $1.81 · H $2.41Jun 29
122
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GAug 2, 2024SC 13GCOMPASS THERAPEUTICS, INC.Nov 27, 2023SC 13GSC 13GDec 30, 2021SC 13GSC 13GNov 12, 2021SC 13GSC 13GAug 10, 2020SC 13GSCH 13GJun 29, 2020SC 13GSC 13GJun 29, 2020SC 13GSCHEDULE 13GFeb 13, 2019
Similar companies
Comparable business profile · signals at a glance